DailyRounds

What DailyRounds does

DailyRounds (legally Neuroglia Health Private Limited) is a Bangalore-based medical education and healthcare professional platform that operates as a subsidiary of M3, a global healthcare company. The company serves a community of 4 million doctors across 9 countries through a multi-product portfolio: Marrow (recorded video lectures, QBank, and test series for NEET PG, NEET SS, and FMGE preparation), DBMCI One (hybrid live and face-to-face coaching for medical PG aspirants), Creator+ (assessment generation tool for medical colleges using 20,000+ MCQs), GliaCircle (wellness benefits and networking for practicing doctors), and India Drug Index (a comprehensive drug information database for clinicians). The platform combines content-led learning, professional networking, and clinical reference tools into an integrated suite targeted at medical students, PG aspirants, practicing doctors, and medical institutions.

The company operates a freemium model with premium subscription access to Marrow and DBMCI One content on an annual billing cadence, while free features (drug database, ECG calculator, library, guidelines) serve as top-of-funnel acquisition. Distribution is mobile-first via iOS and Google Play app stores, complemented by direct web access. Content is produced by top Indian medical faculty, and the QBank is described as the most trusted question bank for NEET PG preparation in India. DBMCI's legacy as the first center in India for medical PG entrance training provides historical credibility.

Beyond core products, DailyRounds runs a Healthcare Incubation Program in partnership with NSRCEL at IIM Bangalore (67 ventures incubated across two cohorts) and maintains CSR programs in education and economic inclusion. The company is privately held with no disclosed venture funding since 2016, relying on M3 parent backing for strategic and operational support. The 400+ employee team is distributed across doctors, engineers, educators, and designers.

Name

DailyRounds

Legal name

Neuroglia Health Private Limited

Website

https://dailyrounds.org

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

251–500 employees

Short description

DailyRounds is a Bangalore-based medical education platform and M3 subsidiary operating Marrow, DBMCI One, Creator+, GliaCircle, and India Drug Index, serving 4 million doctors and medical students across 9 countries through subscription-based learning and clinical reference tools.

Ownership category

akta.pro rank

Product category

Medical Education Technology

NAICS

Exam Preparation and Tutoring (611691), Educational Support Services (61171)

SIC

Services-Health Services (8000)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Medication Aide / Medication Technician (EDAOAJAN)

Keywords

• Medical education platform
• NEET PG preparation
• Clinical case studies
• Medical question bank
• Drug information database

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Subscription Learning Platforms: Marrow and DBMCI One provide recorded video lectures, QBank, test series for medical exam preparation through subscription model

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

DailyRounds operates a medical education and professional support platform serving 4 million doctors across 9 countries. It delivers recorded video lectures, QBank, and Pan-India test series for NEET PG, NEET SS, and FMGE preparation through its Marrow brand, alongside hybrid live and face-to-face classes via DBMCI One. Complementary offerings include Creator+ for institutional assessment generation, GliaCircle for doctor wellness and benefits, and India Drug Index as a clinical drug reference database.

Product overview

DailyRounds operates a multi-product platform for medical education and professional support. The portfolio comprises Marrow (core recorded-video learning platform), DBMCI One (hybrid live classroom), Creator+ (assessment tool for institutions), GliaCircle (benefits network), and India Drug Index (clinical reference database). The company also maintains a blog for medical news and community engagement.

Differentiator

Problem solved

Functional benefit

Brands

• Marrow: Gold-standard learning platform for students preparing for NEET PG, NEET SS, and FMGE. Offers recorded video lectures by India's top medical faculty, QBank, Pan-India Test series, and clinical/concept-based learning for MBBS students.
• DBMCI
• Creator+
• GliaCircle
• India Drug Index (IDI)

Products and services

• Marrow
• DBMCI One Hybrid learning platform providing guided learning through live and face-to-face classes for NEET PG, INI-CET, and FMGE aspirants. Continues the legacy of DBMCI, the first center in India to provide medical PG entrance training, and is led by highly experienced faculty from across the country.
• Creator+ Assessment generation tool that enables medical colleges and institutes to produce customized question papers within minutes. Faculty can choose from 20,000+ MCQs across all MBBS subjects, with questions curated to align with the latest exam patterns for effective student assessment.
• GliaCircle Benefits and wellness network for medical professionals offering curated discounts, wellness support, exclusive travel deals, and a community for doctors. Provides thoughtful support for both professional and personal well-being.
• India Drug Index (IDI) India's most comprehensive drug information resource for clinicians and healthcare practitioners, made by doctors and pharmacologists. Provides drug molecule names, brand names, pricing, indications, contraindications, pharmacology, adverse effects, and alternatives available in the market.

Quantifiable outcome

• 4 million doctors across 9 countries use the platform

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor.

• NSRCEL, IIM BangaloreminorStrategic or Co-development Partner · 1 January 2024Healthcare Incubation Program collaboration to support healthcare startups and innovators. First cohort supported 35 ventures out of 352 applications. Focus on medical devices, healthcare tech, healthcare services, and biotechnology. 67 ventures incubated across 2 cohorts.
• West Bengal State Rural Livelihood MissionminorStrategic or Co-development Partner · 1 January 2023CSR partnership for Economic Inclusion Program in West Bengal, onboarding 1000 women-led households from Nayagram and Jhargram districts.
• Nudge Lifeskills FoundationminorStrategic or Co-development Partner · 1 January 2022CSR partnership for Economic Inclusion Program targeting particularly vulnerable tribal groups (PVTG). Implemented in Jharkhand and West Bengal with focus on sustainable livelihoods for women.
• Vidya PoshakminorStrategic or Co-development Partner · 1 January 2020CSR partnership for education scholarship program. Partnered since 2020 to provide inclusive education in rural Karnataka. Supported 535 students through Nurture Merit program for Bachelor's degrees and Nurture Merit Excel for Medical and Engineering degrees.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• AMBOSS: Globally adopted clinical knowledge and QBank platform for medical students and residents; comparable to Marrow's QBank-plus-reference positioning though skewed toward US/European curricula.
• TrueLearn (now part of Scribe AI): US-focused QBank and analytics platform for medical board prep (USMLE, COMLEX) — similar subscription, question-bank-first monetization model as Marrow.

Direct peers

• Unacademy: Large Indian edtech platform offering NEET PG, FMGE and INI-CET preparation through subscriptions — directly competes with Marrow/DBMCI One for the same fee-paying medical aspirant cohort.
• DAMS (Delhi Academy of Medical Sciences): Long-standing offline/online medical PG coaching brand in India running live classes and test series for NEET PG and INI-CET — directly comparable to DBMCI One's hybrid live+online model.
• DBMCI (Legacy/Original): The original Indian medical PG entrance training brand (first center in India for PG coaching), now continued inside DailyRounds as DBMCI One — a directly comparable legacy coaching model DailyRounds absorbed.
• Pre-PG (Neuroglia Health competitor): India-based medical PG prep focused on question banks, daily tests and gamified prep for NEET PG — same product surface as Marrow and competes head-to-head for the same end-user persona.
• PrepLadder: India-based subscription platform focused on NEET PG, INI-CET and FMGE preparation with video lectures and QBank — directly competes with Marrow for the same Indian medical PG aspirant segment.
• DigiNerve (Jaypee Digital): Jaypee's digital medical education platform for MBBS and NEET PG/SS, with video lectures and QBank — comparable content-and-assessment offering targeting the same MBBS/PG segment.

Broad incumbents

• Elsevier (ClinicalPath/Osmosis): Elsevier's Osmosis and ClinicalPath provide medical education and clinical decision tools globally — broader, incumbent player with adjacent product positioning (video education, clinical reference) overlapping Marrow, GliaCircle, IDI use cases.

Others

• M3 Inc. Parent company of DailyRounds (Neuroglia Health) and global healthcare platform operator (m3.com, MDLinx) serving millions of physicians worldwide — adjacent/parent ecosystem rather than direct competitor, but provides distribution and strategic context.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/dailyrounds
• Facebookfacebook.com/Medengage
• Instagraminstagram.com/daily.rounds
• LinkedInlinkedin.com/company/dailyrounds

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds5 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DailyRounds